Colossal Biosciences would be in talks to raise new capital at a valuation of between $20 billion and $30 billion
When extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils.we discuss that, despite the controversy surrounding the project, the company was building valuable technologies that justify its…




